- Home
- DBI vs ENGN Comparison
DBI vs ENGN Comparison
Compare DBI & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBI
- ENGN
- Stock Information
- Founded
- DBI 1991
- ENGN 1999
- Country
- DBI United States
- ENGN Canada
- Employees
- DBI N/A
- ENGN N/A
- Industry
- DBI Clothing/Shoe/Accessory Stores
- ENGN
- Sector
- DBI Consumer Discretionary
- ENGN
- Exchange
- DBI Nasdaq
- ENGN Nasdaq
- Market Cap
- DBI 178.0M
- ENGN 199.7M
- IPO Year
- DBI 1991
- ENGN N/A
- Fundamental
- Price
- DBI $3.61
- ENGN $4.20
- Analyst Decision
- DBI Hold
- ENGN Buy
- Analyst Count
- DBI 2
- ENGN 7
- Target Price
- DBI $4.75
- ENGN $23.29
- AVG Volume (30 Days)
- DBI 1.1M
- ENGN 92.3K
- Earning Date
- DBI 06-10-2025
- ENGN 06-13-2025
- Dividend Yield
- DBI 5.52%
- ENGN N/A
- EPS Growth
- DBI N/A
- ENGN N/A
- EPS
- DBI N/A
- ENGN N/A
- Revenue
- DBI $3,009,262,000.00
- ENGN N/A
- Revenue This Year
- DBI $2.22
- ENGN N/A
- Revenue Next Year
- DBI $2.18
- ENGN N/A
- P/E Ratio
- DBI N/A
- ENGN N/A
- Revenue Growth
- DBI N/A
- ENGN N/A
- 52 Week Low
- DBI $2.44
- ENGN $2.65
- 52 Week High
- DBI $11.06
- ENGN $11.00
- Technical
- Relative Strength Index (RSI)
- DBI 56.01
- ENGN 57.12
- Support Level
- DBI $3.10
- ENGN $3.71
- Resistance Level
- DBI $3.82
- ENGN $4.42
- Average True Range (ATR)
- DBI 0.23
- ENGN 0.44
- MACD
- DBI 0.01
- ENGN 0.07
- Stochastic Oscillator
- DBI 70.14
- ENGN 85.06
About DBI Designer Brands Inc.
Designer Brands Inc is a designer, producer, and retailer of footwear and accessories. The company operates in three reportable segments: the U.S. Retail segment, the Canada Retail segment and the Brand Portfolio segment. The U.S. Retail segment operates the DSW Designer Shoe Warehouse banner through its direct-to-consumer U.S. stores and e-commerce site. The Canada Retail segment operates The Shoe Company and DSW banners through its direct-to-consumer Canada stores and e-commerce sites. The Brand Portfolio segment earns revenue from the sale of wholesale products to retailers, commissions for serving retailers as the design and buying agent for products under private labels, and the sale of branded products through its direct-to-consumer e-commerce sites.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.